QPS Missouri

Core Competencies

• Phases I and II Clinical Studies.
  • Smoking Cessation.
  • Vaccines.
  • Women’s Health.
  • Bioavailability.
  • Bioequivalence.
  • Nutrition.
• Data management.

Facility

• 240 beds across 5 updated clinical units designed for open-concept layout.
• 24-hour security systems and automatic natural gas-powered generators for power backup.
• Secure on-site archive/document storage with FM-200 gas fire suppression.
• Laminar flow hoods; -70˚C and -20˚C freezers.
• 14 micro-, table-top, and floor centrifuges, and high-speed micro-centrifuges.
• National Institute of Standards and Technology (NIST) calibrated temperature recording devices in refrigerators and freezers.
• Secure pharmacy and retention with DEA-approved safe for Schedule I-IV drugs.
• Local clinical lab provides most results within 24 hours, 7 days a week.

People

• Highly experienced principal investigators (PIs) with as much as 20+ years’ experience in clinical research.
• Leadership team includes technology and CRO services experts with 20+ years of experience.
• Average management team experience includes 10+ years in CRO.
• Dedicated Institutional Review Board (IRB) conducts reviews in accordance with pertinent authorities, including ICH E6: Good Clinical Practice Consolidated Guidance; US FDA (21 CFR Parts 50 and 56); and the US Department of Health.

Accreditation

• 21 successful clinical site US FDA inspections.
• No 483 findings in the past 4 years.

Experience

• Over 1,500 Phase I-IV clinical research studies completed since 1994.
• 100% source and entry quality control.